NEW YORK, Oct. 26 /PRNewswire-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products in China, today announced that the Company will attend several investor conferences in November.
The Company will present at the CIBC World Markets 18th Annual Healthcare Conference on Tuesday, November 6, 2007 at the Waldorf-Astoria Hotel in New York City. Management is currently scheduled to present at 1:55 p.m. ET. On November 15th & 16th, & 19th, management will be meeting with institutional investors at the Credit Suisse China Healthcare Sector Tour in New York City, Boston and London.
The Company will also attend the Lazard Capital Markets Healthcare Conference on November 27-28th and the Piper Jaffray Healthcare Conference on November 27-29th. Both events will take place in New York City.
Institutional investors who are interested in attending these events should contact their institutional sales representatives.
About American Oriental Bioengineering, Inc.
American Oriental Bioengineering is a leading, fully integrated, plant based pharmaceutical and plant based nutraceutical company dedicated to improving health through the development, manufacture and commercialization of modernized plant based products in China.
Safe Harbor Statement
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Bill Zima & Ashley Ammon MacFarlane
Integrated Corporate Relations, Inc.
|SOURCE American Oriental Bioengineering, Inc.|
Copyright©2007 PR Newswire.
All rights reserved